Drugs Made In America Acquisition II Corp.
Organization details
- Legal name
- Drugs Made In America Acquisition II Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Financials
- SIC code
- 6770 — Blank Checks
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DMII
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002040475
Board of directors
-
Catherine Do · DirectorSince 2025
-
Lynn Stockwell · Director · CEO and Exe. Chair of BoardSince 2025
-
Myron W. Shulgan · DirectorSince 2025
-
Sridhar G. Prasad · DirectorSince 2025
Chief executives
Board connections
4 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Drugs Made In America Acquisition Corp. Same sectorvia Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 26, 2025 | Catherine Do Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Myron W. Shulgan Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Worman Glenn C. Officer (CFO) | Other | +100,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Open-market purchase | +700,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Open-market purchase | +700,000 | — | — |
| Sep 26, 2025 | Sridhar G. Prasad Director | Other | +100,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Other | −400,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Other | −400,000 | — | — |
| Sep 26, 2025 | Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner | Open-market sale | −7,966,667 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC 10% owner | Open-market sale | −7,966,667 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Drugs Made In America Acquisition II Corp.
Who is the CEO of Drugs Made In America Acquisition II Corp.?
Lynn Stockwell has been Drugs Made In America Acquisition II Corp.'s CEO & Exe. Chair of the Board since September 2025.
How many directors are on Drugs Made In America Acquisition II Corp.'s board?
Drugs Made In America Acquisition II Corp.'s board has 4 directors: Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="drugs-made-in-america-acquisition-ii-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.